Back to
Hair (Scalp)
Biologic Therapy for Hair Loss and Restoration
Biologic therapy utilizes regenerative biologics, such as extracellular matrix (ECM) or exosomes, to stimulate follicular activity, improve scalp health, and promote hair growth. This minimally invasive treatment is ideal for patients experiencing androgenic alopecia, alopecia areata, or general thinning hair. The protocol below provides a structured guide for delivering safe and effective treatments for hair restoration.
Specialized Dermal Papillary Exosomes: Hair Regeneration Protocol
1. Mechanism of Action
Specialized dermal papillary exosomes consists of exosomes derived from stem cells that have been differentiated into dermal papillary stem cells—the specialized cells responsible for initiating and maintaining hair follicle growth. These exosomes carry lineage-specific signaling molecules that target the follicular microenvironment to stimulate anagen phase entry, support hair matrix cell activity, and counteract miniaturization.
Key biological actions include:
- Activation of Dermal Papilla-Follicle Signaling: Exosomes deliver Wnt agonists, BMP inhibitors, and miRNAs (e.g., miR-218, miR-125b) that activate the follicular niche and prolong anagen phase
- Enhanced Angiogenesis: Through VEGF and angiopoietin signaling, improve blood flow around miniaturized follicles
- Anti-Inflammatory Modulation: Suppress perifollicular inflammatory cytokines (IL-6, TNF-α), often elevated in AGA and telogen effluvium
- ECM Remodeling Support: Contain MMP-regulating cargo and proteins that restore ECM integrity around follicular units
- Stem Cell Niche Maintenance: Exosomal factors help recruit and maintain follicular epithelial stem cells (LGR5⁺, K15⁺), supporting long-term cycling
2. Product & Handling
- Product: Specialized dermal papillary stem cell–derived exosomes
- Volume per vial: 1.0 mL
- Storage: Store at –80°C. Thaw immediately before use. Do not refreeze.
3. Indications
- Androgenetic Alopecia (male and female)
- Telogen Effluvium
- Thinning hair due to aging, hormonal shifts, or post-COVID
- Enhancement after FUE/FUT hair transplantation
- Adjunctive therapy with PRP or microneedling
4. Administration & Protocol
Delivery Options:
- Intradermal injection (manual or device-assisted: U225, EZ Injector)
- Microneedling (0.5–1.5 mm depth)
- Dual application (injection + microneedle)
Dose per Session:
- Mild–moderate thinning: 1.0 mL
- Diffuse or advanced thinning: 1.5–2.0 mL
- Administer uniformly over thinning areas (1 cm injection grid or coverage-based pass)
Frequency & Duration:
- Initial Series: Every 2–4 weeks × 3–4 sessions
- Maintenance: Optional every 3–6 months based on response
5. Physician Post-Treatment Protocol
- Document volume, site coverage, delivery method, and product lot
- Assess for pinpoint bleeding or mild erythema
- Clean treated area with sterile gauze and apply barrier if needed
- Schedule follow-up and discuss optional at-home support
6. Patient Post-Treatment Instructions
- Avoid washing hair, applying products, or excessive sweating for 12–18 hours
- No scalp sun exposure or mechanical stimulation for 24–48 hours
- Resume growth topicals (e.g., minoxidil) 72 hours post-treatment if applicable
- Mild tingling or redness is expected; report any persistent discomfort or swelling
7. Adjunctive Recommendations (Optional)
- Topicals: Stem cell–based conditioners, minoxidil, peptides (e.g., GHK-Cu, PTD-DBM)
- Oral: Nutrafol®, Viviscal®, saw palmetto, collagen, biotin
- Devices: LLLT cap or wand 3x/week
- Lifestyle: Optimize protein intake, sleep hygiene, and hormone balance if applicable
8. Summary
Biologic therapy provides a cutting-edge, minimally invasive solution for hair restoration. By stimulating follicular regeneration and improving scalp health with biologics, this treatment offers a powerful alternative to traditional hair loss therapies. Following this protocol encourages safe, consistent, and effective results, helping patients achieve fuller, healthier hair.